Ucb Biopharma Srl

This study tests whether bimekizumab works better than risankizumab for adults with active psoriatic arthritis (PsA). About 684 participants will receive one of the two drugs for 16 weeks. The main goal is to see how many people get at least 50% improvement in joint symptoms. Bot…

This study looks at the long-term safety and effectiveness of bimekizumab, a drug given as a shot, for adults with active psoriatic arthritis. About 1,100 participants who completed earlier studies will continue treatment to see how well it controls symptoms and what side effects…

This study looks at the long-term safety of a daily injection called zilucoplan in children with a certain type of generalized myasthenia gravis, a disease that causes muscle weakness. Only 8 children who completed a previous study are invited to join. The main goal is to track a…

This early-stage study tests whether the oral drug UCB0022 is safe and tolerable in 32 healthy adults from Caucasian, Japanese, and Chinese backgrounds. Participants receive either the drug or a placebo, and researchers monitor side effects and how the drug moves through the body…